- Home
- /
- News
- /
- Target Identification/ Validation
- /
- September 2010
Target Identification/ Validation News for September 2010
Researchers have created a draft genome sequence for the endangered Tasmanian devil and will use this to find genetic mutations in the transmissible cancer ravaging its population.
17 September, 2010
Charles River Laboratories, a global preclinical contract research organization, now offers BlueScreen HC Screening services for the early detection of genotoxicity.
09 September, 2010
The combined effects of numerous single-letter changes in several genes could be used to predict a woman’s risk of developing the most common form of breast cancer – oestrogen-receptor-positive breast cancer.
07 September, 2010